diethyl <(3-benzyloxyphenyl)methyl>phosphonate | 135203-60-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: diethyl <(3-benzyloxyphenyl)methyl>phosphonate
• 英文别名: diethyl <3-(benzyloxy)benzyl>phosphonate；(3-benzyloxy-benzyl)-phosphonic acid diethyl ester；diethyl [(3-benzyloxyphenyl)methyl]phosphonate；1-(diethoxyphosphorylmethyl)-3-phenylmethoxybenzene
• CAS: 135203-60-0
• 化学式: C₁₈H₂₃O₄P
• 分子量: 334.352
• InChiKey: COLOFABMKSNZCI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  23
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  diethyl <(3-benzyloxyphenyl)methyl>phosphonate 在 碘 、 sodium hydride 作用下， 以 四氢呋喃 、 环己烷 为溶剂， 反应 23.0h， 生成 demethyl batatasin IV
  参考文献：
  名称：

  Naturally occurring Batatasins and their derivatives as α-glucosidase inhibitors

  摘要：

  自然产生的薯蓣素及其衍生物对α-葡萄糖苷酶显示出显著的抑制作用，为抗糖尿病药物开发提供了有希望的化学支架。

  DOI：

  10.1039/c5ra15328j
• 作为产物：
  描述：

  3-苄氧基苯甲醛 在 sodium tetrahydroborate 、 三溴化磷 、 四丁基碘化铵 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 17.0h， 生成 diethyl <(3-benzyloxyphenyl)methyl>phosphonate
  参考文献：
  名称：

  Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogs of piceatannol

  摘要：

  A series of hydroxylated trans-stilbenes related to the antileukemic natural product trans-3,3',4,5'-tetrahydroxystilbene (piceatannol) (1) has been prepared and tested for inhibition of the lymphoid cell lineage-specific protein-tyrosine kinase p56lck, which plays an important role in lymphocyte proliferation and immune function. A number of the analogues displayed enhanced enzyme inhibitory activity relative to the natural product. Reduction of the double bond bridging the two aromatic rings and benzylation of the phenolic hydroxyl groups was found to decrease activity significantly. The most potent compounds in the series proved to be trans-3,3',5,5'-tetrahydroxystilbene, trans-3,3',5-trihydroxystilbene, and trans-3,4,4'-trihydroxystilbene.

  DOI：

  10.1021/jm00072a015

文献信息

• Biaryl Ether Urea Compounds
  申请人：FAY Lorraine Kathleen

  公开号：US20080261941A1

  公开（公告）日：2008-10-23

  The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

  本发明涉及式(I)的化合物或其药用可接受的盐；制备该化合物的方法；制备该化合物所用的中间体；含有该化合物的组合物；以及利用该化合物治疗与脂肪酸酰胺水解酶(FAAH)活性相关的疾病或症状。
• Bis(bibenzyl) ethers from Pellia endiviifolia
  作者：Toshihiro Hashimoto、Hazimu Suzuki、Motoo Tori、Yoshinori Asakawa

  DOI：10.1016/0031-9422(91)84201-3

  日期：1991.1

  Abstract Two new bis(bibenzyl) ethers, perrottetin E-11′-methyl ether and 14-hydroxyperrottetin E-11′-methyl ether were isolated from an ethyl acetate extract of the liverwort Pellia endiviifolia together with the previously known bis(bibenzyl) ether, perrottetin E and their structures characterized by spectroscopic methods, chemical evidence and total synthesis. The present results strongly support

  摘要 两种新的双（联苄基）醚，perrottetin E-11'-甲基醚和 14-羟基 perrottetin E-11'-甲基醚与先前已知的双（联苄基）醚一起从苔藓 Pellia endiviifolia 的乙酸乙酯提取物中分离出来。 ，perrottetin E 及其结构特征的光谱方法，化学证据和全合成。目前的结果强烈支持舒斯特对 Metzgeriales 和 Jungermanniales 的系统发育分类。
• Biaryl ether urea compounds
  申请人：Pfizer Inc.

  公开号：US08044052B2

  公开（公告）日：2011-10-25

  The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

  本发明涉及式（I）化合物或其药学上可接受的盐；制备该化合物的方法；制备该化合物的中间体；含有该化合物的组合物；以及使用该化合物治疗与脂肪酸酰胺水解酶（FAAH）活性相关的疾病或病况的用途。
• HASHIMOTO, TOSHIHIRO;SUZUKI, HAZIMU;TORI, MOTOO;ASAKAWA, YOSHINORI, PHYTOCHEMISTRY, 30,(1991) N, C. 1523-1530
  作者：HASHIMOTO, TOSHIHIRO、SUZUKI, HAZIMU、TORI, MOTOO、ASAKAWA, YOSHINORI

  DOI：——

  日期：——
• BIARYL ETHER UREA COMPOUNDS
  申请人：Pfizer Products Inc.

  公开号：EP2076508A2

  公开（公告）日：2009-07-08